A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes

Acne dysbiosis happens when there is a microbial imbalance of the over-growth of Propionibacterium acnes (P. acnes) in the acne microbiome. In our previous study, we demonstrated that Staphylococcus epidermidis (S. epidermidis, a probiotic skin bacterium) can exploit glycerol fermentation to produce short-chain fatty acids (SCFAs) which have antimicrobial activities to suppress the growth of P. acnes. Unlike glycerol, sucrose is chosen here as a selective fermentation initiator (SFI) that can specifically intensify the fermentation activity of S. epidermidis, but not P. acnes. A co-culture of P. acnes and fermenting S. epidermidis in the presence of sucrose significantly led to a reduction in the growth of P. acnes. The reduction was abolished when P. acnes was co-cultured with non-fermenting S. epidermidis. Results from nuclear magnetic resonance (NMR) analysis revealed four SCFAs (acetic acid, butyric acid, lactic acid, and succinic acid) were detectable in the media of S. epidermidis sucrose fermentation. To validate the interference of S. epidermidis sucrose fermentation with P. acnes, mouse ears were injected with both P. acnes and S. epidermidis plus sucrose or phosphate buffered saline (PBS). The level of macrophage-inflammatory protein-2 (MIP-2) and the number of P. acnes in ears injected with two bacteria plus sucrose were considerably lower than those in ears injected with two bacteria plus PBS. Our results demonstrate a precision microbiome approach by using sucrose as a SFI for S. epidermidis, holding future potential as a novel modality to equilibrate dysbiotic acne.

[1]  L. Maia,et al.  Does the presence of sucrose in pediatric antibiotics influence the enamel mineral loss and the Streptococcus mutans counts in dental biofilm? , 2015, Brazilian dental journal.

[2]  S. Datta,et al.  Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection , 2015, PloS one.

[3]  L. Leibovici,et al.  Combination therapy for carbapenem-resistant Gram-negative bacteria. , 2014, The Journal of antimicrobial chemotherapy.

[4]  D. Greco,et al.  IL-17/Th17 Pathway Is Activated in Acne Lesions , 2014, PloS one.

[5]  R. Gallo,et al.  Propionic acid and its esterified derivative suppress the growth of methicillin-resistant Staphylococcus aureus USA300. , 2014, Beneficial microbes.

[6]  A. Smyth,et al.  Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis. , 2013, The Cochrane database of systematic reviews.

[7]  J. Cove,et al.  A Honey Trap for the Treatment of Acne: Manipulating the Follicular Microenvironment to Control Propionibacterium acnes , 2013, BioMed research international.

[8]  Chun-Ming Huang,et al.  Fermentation of Propionibacterium acnes, a Commensal Bacterium in the Human Skin Microbiome, as Skin Probiotics against Methicillin-Resistant Staphylococcus aureus , 2013, PloS one.

[9]  Rob Lavigne,et al.  Learning from Bacteriophages - Advantages and Limitations of Phage and Phage-Encoded Protein Applications , 2012, Current protein & peptide science.

[10]  T. Ulven Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets , 2012, Front. Endocrin..

[11]  A. Buckling,et al.  Gut dysbiosis in cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[12]  C. Zouboulis,et al.  An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case–control study , 2012, The British journal of dermatology.

[13]  Ishtiaq Qadri,et al.  Bacteriophages and their implications on future biotechnology: a review , 2012, Virology Journal.

[14]  H. Kong,et al.  Skin Microbiome: Looking Back to Move Forward , 2011, The Journal of investigative dermatology.

[15]  R. Curi,et al.  Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.

[16]  Takafumi Hara,et al.  Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. , 2011, Journal of pharmaceutical sciences.

[17]  S. Garland Short chain fatty acids may elicit an innate immune response from preadipocytes: a potential link between bacterial infection and inflammatory diseases. , 2011, Medical hypotheses.

[18]  Chun-Ming Huang,et al.  Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris. , 2011, Vaccine.

[19]  A. Félix,et al.  Cell death induced by HDACS inhibitors in ovarian cancer cell lines (serous and clear cells carcinomas) – role of NOTCH, TP53 and FN1 , 2010, BMC Proceedings.

[20]  M. Picardo,et al.  KdPT, a Tripeptide Derivative of α-Melanocyte–Stimulating Hormone, Suppresses IL-1β–Mediated Cytokine Expression and Signaling in Human Sebocytes , 2010, The Journal of Immunology.

[21]  K. Jahreis,et al.  Ins and outs of glucose transport systems in eubacteria. , 2008, FEMS microbiology reviews.

[22]  B. Dréno,et al.  A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  R. Fried,et al.  Psychological problems in the acne patient , 2006, Dermatologic therapy.

[24]  J. Lindh,et al.  16S rRNA Gene-Based Identification of Midgut Bacteria from Field-Caught Anopheles gambiae Sensu Lato and A. funestus Mosquitoes Reveals New Species Related to Known Insect Symbionts , 2005, Applied and Environmental Microbiology.

[25]  Jenny Kim Review of the Innate Immune Response in Acne vulgaris: Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses , 2005, Dermatology.

[26]  D. Persing,et al.  CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. , 2005, Microbiology.

[27]  Erole Hobdy,et al.  AN-9 (Titan). , 2004, Current opinion in investigational drugs.

[28]  J. Chirife,et al.  Specific solute effects on Staphylococcus aureus cells subjected to reduced water activity. , 1993, International journal of food microbiology.

[29]  J. Rasmussen,et al.  Intralesional corticosteroids in the treatment of nodulocystic acne. , 1983, Archives of dermatology.

[30]  R. Stoughton,et al.  Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes. , 1982, Journal of the American Academy of Dermatology.

[31]  Afanas'eva Ti,et al.  Importance of carbohydrate tests for interspecies differentiation of staphylococci , 1978 .

[32]  A. Kligman An overview of acne. , 1974, The Journal of investigative dermatology.

[33]  C. W. Moss,et al.  Cultural Characteristics and Fatty Acid Composition of Corynebacterium acnes , 1967, Journal of bacteriology.

[34]  K. Lewis,et al.  Fermentation of Sugar Acids by Bacteria , 1940, Journal of bacteriology.

[35]  Chun-Ming Huang,et al.  Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris , 2013, Applied Microbiology and Biotechnology.

[36]  J. D. Del Rosso,et al.  A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. , 2010, Cutis.

[37]  Raied Taha Al Naama EVALUATION OF INHIBITORY EFFECT OF HONEY ON SOME BACTERIAL ISOLATES , 2009 .

[38]  Hee-Sun Kim,et al.  Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells : Involvement of NF-κB and ERK signaling pathways , 2007 .

[39]  M. Göttlicher Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. , 2004, Annals of hematology.

[40]  N. Shcherbakova,et al.  [Importance of carbohydrate tests for interspecies differentiation of staphylococci]. , 1978, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.